Moreau et al. (Moreau et al., 2011) reported that the HIF-1 pathway of sporadic ALS patients showed significant abnormalities during hypoxia and could be a novel target for ALS therapy. The gene discussed is HIF1A; the disease is amyotrophic lateral sclerosis.